Both in Biotechnology
Adaptive Biotechnologies vs CG Oncology
Over the past year ADPT returned +48.8% and CGON returned +52.9%; their daily moves had a correlation of 0.20.
ADPT +48.8% CGON +52.9%Growth of $1, one year, split-adjusted
| Metric | ADPT | CGON |
|---|---|---|
| Price | $25.80 | $64.06 |
| Market cap | $4.12B | $5.68B |
| Today | +2.95% | +3.39% |
| 1 month | −13.5% | −6.8% |
| 6 months | +87.2% | −4.6% |
| Year to date | +58.9% | +54.3% |
| 1 year | +48.6% | +48.0% |
| Revenue growth (YoY) | +21.5% | — |
| Gross margin | 71.8% | −239.2% |
| Net margin | −55.6% | −6832.8% |
| P/E (TTM) | — | — |
| Price / sales | 13.4× | 911.7× |
| Net cash | $9.4M | $1.03B |
| Dividend yield | — | — |
| Volatility (60d) | 51.1% | 41.6% |
| Short % of float | 10.0% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).